Regeneron Pharmaceuticals Inc
€545.55
EUR
Last updated on --.
24h volume889.77K
24h highest557.58 EUR
24h lowest543.98 EUR
24h Price movement-0.68%
REGN recent prices
24 Hours
-0.68%-€3.758
30 days
-13.91%-€89.06
60 days
-13.43%-€85.20
90 days
-16.86%-€111.71
Key data
Previous close549.31 EUR
Market cap58.57B EUR
Volume889.77K
P/E ratio15.400000
Dividend yield (TTM)0.01%
Dividend amount0.80821 EUR
Next ex-dividend date20 May 2026
Next payment date4 Jun 2026
EPS diluted (TTM)36.2750 EUR
Net income (FY)3.80B EUR
Revenue (FY)12.83B EUR
Last report date29 Apr 2026
About Regeneron Pharmaceuticals Inc
HeadquartersTARRYTOWN
Employees (FY)15.41K
Revenue per employee (FY)832.44K EUR
Net income per employee (FY)246.80K EUR
Listed onNasdaq
REGN conversion tables
 |  |
|---|---|
| 0.5 REGN | 272.77 EUR |
| 1 REGN | 545.55 EUR |
| 5 REGN | 2,727.75 EUR |
| 10 REGN | 5,455.51 EUR |
| |
|---|---|
| 0.5 EUR | 0.0009165 REGN |
| 1 EUR | 0.001833 REGN |
| 5 EUR | 0.009165 REGN |
| 10 EUR | 0.01833 REGN |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
REGN is trading at €545.55, -0.68% over the last 24 hours. Track live moves on the price chart at the top of this page.
The REGN stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. REGN is currently trading at €545.55, -0.68% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on REGN price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. REGN's P/E ratio is currently 15.400000 — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from REGN; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against REGN's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
Regeneron Pharmaceuticals Inc's market cap is currently 58.57B EUR. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume889.77K
24h highest557.58 EUR
24h lowest543.98 EUR
24h Price movement-0.68%
Start trade with REGN Perpetual
Sign up to trade